NorthCoast Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-123,867
Closed -$18.1M 213
2017
Q3
$18.1M Buy
+123,867
New +$16.9M 2.12% 16
2015
Q4
Sell
-12,490
Closed -$1.35M 209
2015
Q3
$1.35M Hold
12,490
0.07% 112
2015
Q2
$1.45M Hold
12,490
0.07% 114
2015
Q1
$1.44M Sell
12,490
-532
-4% -$63.6K 0.07% 110
2014
Q4
$1.46M Sell
13,022
-384,280
-97% -$40.5M 0.07% 105
2014
Q3
$37.7M Sell
397,302
-198,700
-33% -$17.9M 1.86% 26
2014
Q2
$51.2M Sell
596,002
-17,194
-3% -$1.31M 2.97% 13
2014
Q1
$42.8M Buy
613,196
+47,832
+8% +$3.79M 2.79% 19
2013
Q4
$47.8M Buy
565,364
+19,182
+4% +$1.52M 3.01% 16
2013
Q3
$42.1M Sell
546,182
-176,984
-24% -$12.4M 2.87% 19
2013
Q2
$42.3M Buy
+723,166
New +$43.5M 3.22% 8

Other funds holding CELG

NorthCoast Asset Management's CELG Position: Q4 2017 in Review

NorthCoast Asset Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 123,867 shares — an estimated $18.1M sold.

NorthCoast Asset Management first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $51.2M in Q2 2014. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • NorthCoast Asset Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • NorthCoast Asset Management sold 123,867 Celgene Corp shares in Q4 2017, an estimated $18.1M.
  • NorthCoast Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
  • NorthCoast Asset Management's Celgene Corp position peaked at $51.2M in Q2 2014.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on NorthCoast Asset Management's 13F filing for Q4 2017, filed 5 Feb 2018.